[Editorial] France may be back, but the old ways persist for INSERM
On June 12, the term of the Chief Executive Officer (CEO) of the French National Institute of Health and Medical Research (INSERM) ends. The office of the current CEO, Yves Lévy, came under heavy criticism after the appointment of the minister of health, Agnès Buzyn, in May, 2017. Lévy is Buzyn’s husband, an obvious potential conflict of interest for the head of an institute that is run under the dual auspices of the Ministries of Health and Research. This discrepancy was seemingly rectified, on May 29, 2017, by a decree stating that acts relating to INSERM would be carried out by the French prime minister, not Buzyn.